© Copyright 2026 American Medical Association. All rights reserved.
The procedure described by CPT® Code 55874 involves the transperineal placement of biodegradable material through a series of carefully executed steps aimed at protecting healthy rectal tissue during radiotherapy for prostate cancer. This procedure is particularly significant as it utilizes a biodegradable spacer, which is injected between the anterior rectum and the prostate. The primary goal of this intervention is to minimize radiation exposure to the rectal tissue, thereby reducing the risk of potential side effects associated with radiotherapy. The procedure is performed under image guidance, typically using transrectal ultrasound, which allows for precise placement of the biodegradable material. The use of an 18-gauge needle facilitates the injection of the hydrogel, which quickly solidifies into a spacer, providing immediate protection. Over time, this biodegradable material will decompose back into a liquid form, typically after approximately three months, ensuring that it does not remain in the body indefinitely. This innovative approach represents a significant advancement in the management of prostate cancer treatment, enhancing patient safety and comfort during the therapeutic process.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.